Showing results (1-10 of 203) with videos related to
Sort By:
Pageof 21
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1995
Lamotrigine in Parkinson's disease--a double blind studyF Zipp, F Bürklin, K Stecker, et al.Journal of Neural Transmission. Supplementum|January 1, 1995
Fluctuations in Parkinson's disease. Pathogenetic significance of levodopa's cerebral pharmacokinetics and pharmacodynamicsH Baas, S Harder, L Demisch, et al.Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1993
Lamotrigine--antiparkinsonian activity by blockade of glutamate release?F Zipp, H Baas, P A FischerJournal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1993
Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's diseaseH Baas, K Stecker, P A FischerClinical Neuropharmacology|May 14, 1998
Pharmacodynamics of levodopa coadministered with apomorphine in parkinsonian patients with end-of-dose motor fluctuationsH Baas, S Harder, F Bürklin, et al.Medicine and Science in Sports and Exercise|December 10, 1999
Therapeutic value of exercise training in Parkinson's diseaseI Reuter, M Engelhardt, K Stecker, et al.European Neurology|January 1, 1987
Preliminary experience with Madopar HBS: clinical observations and plasma levodopa concentrationsP A Fischer, H BaasJournal of Neural Transmission. Supplementum|January 1, 1987
Therapeutic efficacy of R-(-)-deprenyl as adjuvant therapy in advanced parkinsonismP A Fischer, H BaasJournal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1990
Treatment of parkinsonian tremor with clozapineP A Fischer, H Baas, R HefnerDer Nervenarzt|April 1, 1994
[Slow-release L-dopa vs. standard L-dopa in Parkinson patients in various stages of the disease. Studies of pharmacokinetics and motor effectiveness]N Bergemann, H Baas, P A FischerPageof 21